Williams Gregory C. 4
4 · Eloxx Pharmaceuticals, Inc. · Filed Feb 26, 2020
Insider Transaction Report
Form 4
Williams Gregory C.
Chief Operating Officer
Transactions
- Award
Stock Options
2020-02-25+400,000→ 400,000 totalExercise: $3.59Exp: 2030-02-25→ Common Stock (400,000 underlying) - Award
Restricted Stock Units
2020-02-25+200,000→ 200,000 total→ Common Stock (200,000 underlying)
Footnotes (5)
- [F1]The stock options were issued pursuant to the Issuer's 2018 Equity Incentive Plan.
- [F2]The option vests and becomes exercisable over a four-year period, with one-fourth of the shares of common stock underlying the options vesting on February 25, 2021, and the remainder vesting in twelve equal quarterly installments thereafter.
- [F3]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
- [F4]The restricted stock units will vest as follows: 25% after first anniversary and ratably each quarter over the next three years thereafter subject to the reporting person's continued employment with the Issuer, which vesting may be accelerated in certain circumstances. Vested shares will be delivered promptly after each vesting date.
- [F5]The restricted stock units were issued pursuant to the Issuer's 2018 Equity Incentive Plan.